(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)
Capstan Medical Achieves Milestone in Robotic-Assisted Heart Valve Replacement
Capstan Medical has successfully completed its first robotic-assisted mitral valve replacement procedures in two patients, marking a breakthrough in structural heart disease treatment. Current mitral valve replacement options exclude many patients due to anatomical constraints. Capstan’s minimally invasive approach aims to expand access by developing a compact valve, robotic-assisted catheter delivery system, and surgical platform.
Performed in Santiago, Chile, these procedures offer hope for patients with mitral regurgitation, a condition where blood leaks due to improper valve closure. Existing treatments, such as Abbott’s MitraClip and Edwards' Pascal system, focus on repairs rather than full replacements.
Backed by $110 million in funding, Capstan aims to launch a pivotal trial leading to FDA approval by 2028. The company’s robotic system is still under development, but early success suggests it could revolutionize heart valve interventions.
18-03-2025